Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009

NCT05134922 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Breast Neoplasm Malignant Female

Interventions

DRUG: Gedatolisib

Sponsor

Celcuity Inc